Walkers Offshore Academy

Walkers will be hosting its first Walkers Offshore Academies on 25 October in Beijing and 27 October in Shanghai.

Read More


Following the recent result in the United Kingdom's EU referendum, Walkers has created a Brexit page dedicated to providing our clients relevant information about the jurisdictions in which we practice.

Read More

Walkers Asset Recovery

Fifteen Walkers lawyers were recognised in the 2017 Who's Who Legal Asset Recovery guide. This is more than any other global law firm worldwide.

Read More

BVI Office Update

The financial services industry has successfully implemented business recovery plans

Read More

Walkers is a leading international law firm. We advise on the laws of Bermuda*, the British Virgin Islands, the Cayman Islands, Guernsey, Ireland and Jersey.

Ireland Trainee Solicitor Programme

Walkers is pleased to announce that we are now accepting applications for our 2018/19 Ireland Trainee Solicitor Programme.


More Information

Browse Professionals
by last name

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Find a Professional
Search by one or more criteria

Walkers Acts on Acquisition of Corporate Services Business of Deutsche Bank

Walkers is pleased to announce that it has acted as Cayman Islands, Guernsey and Jersey legal counsel to long standing client Vistra in the acquisition of the Corporate Services business of Deutsche Bank.

Ranked among the top four corporate service providers globally, Vistra is a versatile group of professionals, providing a uniquely broad range of services and solutions. Vistra has 3,500 staff in 74 offices across 44 jurisdictions, whose capabilities span international incorporations to trust, fiduciary, private client services, and fund administration.

Deutsche Bank’s Corporate Services business has long been a leading service provider of administration to special purpose vehicles and holding companies with over 40 years expertise in this sector. Corporate Services is part of the Global Transaction Banking division and provides administration, domiciliation, accounting and management services from eight locations.

The Walkers team was led by Arwel Lewis (Hong Kong), Jonathan Heaney (Jersey), Lucy Frew (Cayman Islands) and Louise Hall (Guernsey), with assistance from William Lee (Hong Kong), Sophie Reguengo (Jersey) and Niall MacDonald (Jersey).

Walkers worked with onshore counsel Latham and Watkins (Hong Kong).

Taylors Acts for SoftBank Vision Fund Investment in Roivant Sciences

Taylors (in association with Walkers) has acted as Bermuda counsel to SoftBank Vision Fund, which led a $1.1 billion equity investment in Roivant Sciences. The investment, which includes existing shareholder participation, is intended to accelerate the launch of new subsidiaries within and beyond the biopharma industry. The Taylors team, led by partner Jonathan Betts, worked alongside Cooley LLP, as lead US counsel. 

“Roivant has attracted world-class talent in its pursuit of developing and commercializing drugs that target large unmet medical needs,” said Akshay Naheta, managing director of SoftBank Group International, in a news release. “We are impressed with the ambition and track record of the Roivant team and look forward to supporting them in the next step of their journey, as they look to effectively harness technology and leverage big data across all aspects of their business.”

Roivant, which was founded in 2014, is dedicated to transformative innovation in healthcare. It focuses on realizing the full potential of promising biomedical research by developing and commercializing novel therapies across diverse therapeutic areas. It partners with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly developed and delivered to patients.

The SoftBank Vision Fund invests globally in the businesses and technologies that will enable the next stage of the Information Revolution, and make tomorrow’s world leading businesses possible. It invests across all technology sectors and geographies, including computational biology, data-driven healthcare and technology-enabled pharmaceutical businesses.